Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is -19.55% vs -21.92% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -19.05% vs -24.85% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is -18.51% vs -23.12% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is -1.59% vs -22.22% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Jafron Biomedical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is -15.82% vs 22.99% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -19.55% vs -21.92% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -26.43% vs 176.44% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -19.05% vs -24.85% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is -13.96% vs 100.32% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -18.51% vs -23.12% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 0.00% vs -6.77% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -1.59% vs -22.22% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025






